TrialClinical and translational gastroenterology2025

Symptomatic Improvement in Adults and Adolescents With Eosinophilic Esophagitis Requires Higher Systemic Dupilumab Exposure Than Histologic Response.

Evan S Dellon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.